23andMe is getting serious about drug development — and it could signal a fresh approach to finding new medicines

September 17, 2017
47 Views

23andMe, a company known for its consumer genetics test, is also looking to develop new drugs.
The company raised $250 million on Tuesday, and the funding will in part go toward drug development.
While drug development and consumer genetics tests might seem like vastly different businesses, the link could be critical to finding new treatments for diseases.

23andMe is getting serious about drug development.

On Tuesday, 23andMe announced that it had raised $250 million valuing the company at a reported $1.5 billion, and said that that funding will in part go toward developing 23andMe-made therapeutics. It’ll also help the …read more

You may be interested

Animal cruelty: RSPCA seeking identity of drivers who strapped puppy in cage to roof of car – Courier Mail
australia
shares20 views
australia
shares20 views

Animal cruelty: RSPCA seeking identity of drivers who strapped puppy in cage to roof of car – Courier Mail

doyelteam - Sep 25, 2017

Courier MailThese were the conditions a young puppy was subjected to over the weekend when it was spotted in an…

Eunji Ban murder-accused had gone out looking to kill someone: Court – The Sydney Morning Herald
australia
shares22 views
australia
shares22 views

Eunji Ban murder-accused had gone out looking to kill someone: Court – The Sydney Morning Herald

doyelteam - Sep 25, 2017

The Sydney Morning HeraldThe legal team for a man accused of murdering a South Korean student in the Brisbane CBD…

THE CHATBOT MONETIZATION REPORT: Sizing the market, key strategies, and how to navigate the chatbot opportunity (FB, AAPL, GOOG)
technology
shares28 views
technology
shares28 views

THE CHATBOT MONETIZATION REPORT: Sizing the market, key strategies, and how to navigate the chatbot opportunity (FB, AAPL, GOOG)

doyelteam - Sep 25, 2017

This is a preview of a research report from BI Intelligence, Business Insider's premium research service. To learn more about…